According to the report, the medical robotics systems market is presumed to witness an exponential CAGR of 21.5%. The market for medical robotics systems, which was valued at US$ 2,257.8 Mn in 2018 is anticipated to reach US$ 10,710.6 Mn by the end of 2026. It is expected to gain traction as market players are focusing constantly on introducing innovative and advanced surgical robots.
The increasing efficiency of robots in performing complicated tasks such as surgeries is leading to wider adoption of medical robots and thus, boosting the global Medical Robotic Systems Market, says Fortune Business Insights in their new study. The titled,” Medical Robotic Systems Market: Global Market Analysis, Insights, and Forecast, 2019-2026”.
Major Leading Players Mentioned:
- Zimmer Biomet
- Intuitive Surgical Inc
- Smith & Nephew
- Ekso Bionics
Get Sample PDF Brochure:
In terms of product type, the global medical robotic systems market was dominated by the surgical robot’s segment in 2018 and the segment is likely to continue dominating the market in the coming years. This segment accounted for 64.8% of the market in 2018. This is attributable to the rapid advancement in surgical robots and their efficient performance in minimally invasive surgeries.
Rising Cases of Co-morbidity Diseases Boosting Market
Various factors are aiding growth of the booming medical robotic systems market including the rise in number of trauma injury cases, advancement in technology and increasing healthcare facilities and expenditures. Besides this, the rise in geriatric population and the co-morbidity diseases is creating growth opportunities for surgical procedures. The advent of robots into the medical industry is considered an important factor creating lucrative growth opportunities for the overall market in the long run.
The rapid shift from conventional open surgeries towards minimally invasive surgical procedures is another major factor accelerating growth of the market. The efficiency of surgical robots to perform laparoscopic surgical procedures is getting higher by the day. This is further helping to increase the demand for medical robots, thus boosting the market globally.
However, the market may face challenges in terms of the safety concerns related to using robotic surgical tools. This, coupled with the high installation, upgradation, and maintenance cost of medical robots, may restrict its growth during the forecast period.
Nevertheless, the increasing funding on medical robots, advantages offered by robot-assisted surgeries, and training services in rehabilitation centers are presumed to bring lucrative growth opportunities for the global medical robotic systems market in the coming years.
Browse Complete Report:
North America to Hold Dominance on Account of Higher Per Capita Income to Afford Robotic Surgical Procedures
Fortune Business Insights foresees the global medical robotic systems market to be dominated by North America. This is owing to the increasing number of patients undergoing minimally invasive surgeries and the high per capita income of people in the developed nations of the U.S., and Canada. In addition to that, the number of patients suffering from neurological disorders is also increasing which further propels the demand for rehabilitation and surgical robots for treatment facilities along with the others. Such factors are responsible for North America to enjoy a dominant position in the global medical robotic systems market.
Market players are investing huge sums in the research and development for upgrading surgical robots and other medical robots in order to provide better medical assistance.
More Trending Topics from Fortune Business Insights:
What’s driving the Botulinum Toxin Market Growth? Prominent Players ALLERGAN, Ipsen Pharma, Merz Pharma, Medytox, US WorldMeds, LLC (Solstice Neurosciences, LLC), Galderma laboratories, Lanzhou Institute of Biological Products Co., Ltd, Revance Therapeutics, Inc.
What’s driving the Legal Marijuana Market Growth? Prominent Players: Aurora Cannabis, Aphria, Inc, Canopy Growth Corporation, MedReleaf Corp, Cronos Group, Inc, GW Pharmaceuticals, CannTrust Holdings, Inc, VIVO Cannabis, Inc, Tilray, OrganiGram Holdings